Nigel Langley
The Power List 2021 – Small Molecules
Global Technology Director at BASF
Langley has written over 100 scientific publications and co-edited two books. He is also an adjunct professor at the University of Mississippi and a Fellow of the UK’s Royal Society of Chemistry. In 2018, he was awarded the Industry Research Achievement Award in Excipient Technology by the IPEC Foundation. He has been a member of the Executive Committee at IPEC Americas since 2010 and is currently Chair Elect. He is also helping to lead the Novel Excipients Initiative for IPEC Americas in collaboration with the IQ Pharma Consortium. “I have a passion and interest in innovation especially in the area of pharmaceutical excipients. I am hopeful that, in the coming years, excipient innovation will become a key driver in the pharmaceutical industry, in both biologics and small molecule drug development. Without the opportunity to develop new excipients that have been specifically designed to help address current and future formulation challenges – for example, in improving the stability of biologics and in the area of poorly soluble small molecules – these challenges will remain unmet and, as a consequence, optimal medicines will not be available to the patient.”
